An Open-label, Multicenter Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Study Number
3718023
Phase
I
Age Group
Adult
Principal Investigator
Grace Dy
Purpose

An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer

Check your eligibility for this trial
Check now
Full Title

An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer

ClinicalTrials.Gov ID
NCT06179069

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.